Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


Articles published in Acta Neurol Scand

Retrieve available abstracts of 62 articles:
HTML format
Text format



Single Articles


    March 2019
  1. SEDANO MJ, Orizaola P, Gallardo E, Garcia A, et al
    A unicenter, prospective study of Guillain-Barre syndrome in Spain.
    Acta Neurol Scand. 2019 Mar 31. doi: 10.1111/ane.13092.
    PubMed     Text format     Abstract available


  2. CORTES-MARTINEZ A, Matias-Guiu JA, Pytel V, Montero P, et al
    What is the meaning of PASAT rejection in Multiple Sclerosis?
    Acta Neurol Scand. 2019 Mar 25. doi: 10.1111/ane.13090.
    PubMed     Text format     Abstract available


    February 2019
  3. ENGELS K, Schiffmann I, Weierstall R, Rahn AC, et al
    Emotions towards magnetic resonance imaging in people with multiple sclerosis.
    Acta Neurol Scand. 2019 Feb 25. doi: 10.1111/ane.13082.
    PubMed     Text format     Abstract available


  4. DE BERNARDO M, Vitiello L, Rosa N
    Optic nerve ultrasound measurement in multiple sclerosis.
    Acta Neurol Scand. 2019 Feb 5. doi: 10.1111/ane.13072.
    PubMed     Text format     Abstract available


  5. CANDELIERE MERLICCO A, Gabaldon Torres L, Villaverde Gonzalez R, Fernandez Romero I, et al
    Response to: Comment on "Transorbital ultrasonography for measuring optic nerve atrophy in multiple sclerosis".
    Acta Neurol Scand. 2019 Feb 5. doi: 10.1111/ane.13076.
    PubMed     Text format     Abstract available


  6. SANDROFF BM, Baird JF, Silveira SL, Motl RW, et al
    Response heterogeneity in fitness, mobility and cognition with exercise-training in MS.
    Acta Neurol Scand. 2019;139:183-191.
    PubMed     Text format     Abstract available


  7. DASH D, Pandey S
    Movement disorders associated with neuronal antibodies.
    Acta Neurol Scand. 2019;139:106-117.
    PubMed     Text format     Abstract available


    January 2019
  8. NAGAPPA M, Mahadevan A, Yashwanth G, Patil SA, et al
    Autoantibodies in Acquired Myasthenia gravis: Clinical Phenotype & Immunological correlation.
    Acta Neurol Scand. 2019 Jan 28. doi: 10.1111/ane.13071.
    PubMed     Text format     Abstract available


  9. RAHN AC, Kopke S, Stellmann JP, Schiffmann I, et al
    Magnetic resonance imaging as a prognostic disability marker in clinically isolated syndrome: A systematic review.
    Acta Neurol Scand. 2019;139:18-32.
    PubMed     Text format     Abstract available


    November 2018
  10. PIRTTISALO AL, Soilu-Hanninen M, Sipila JOT
    Multiple sclerosis epidemiology in Finland: regional differences and high incidence.
    Acta Neurol Scand. 2018 Nov 27. doi: 10.1111/ane.13057.
    PubMed     Text format     Abstract available


  11. DAL-BIANCO A, Wenhoda F, Rommer PS, Weber M, et al
    Do Elevated Autoantibodies in Patients With Multiple Sclerosis Matter ?
    Acta Neurol Scand. 2018 Nov 17. doi: 10.1111/ane.13054.
    PubMed     Text format     Abstract available


  12. MELBYE P, Olsson A, Hansen TH, Sondergaard HB, et al
    Short-Chain Fatty Acids and Gut Microbiota in Multiple Sclerosis.
    Acta Neurol Scand. 2018 Nov 14. doi: 10.1111/ane.13045.
    PubMed     Text format     Abstract available


  13. STEENHOF M, Nielsen NM, Stenager E, Kyvik K, et al
    Distribution of disease courses in familial versus sporadic multiple sclerosis.
    Acta Neurol Scand. 2018 Nov 9. doi: 10.1111/ane.13044.
    PubMed     Text format     Abstract available


  14. DOURADO JUNIOR MET, Fernandes UT, Ramos ES, Vital ALF, et al
    Egos has a reduced capacity to predicts GBS prognosis in Northeast Brazil.
    Acta Neurol Scand. 2018;138:459-462.
    PubMed     Text format     Abstract available


    October 2018
  15. HOLMOY T, Rosjo E, Zetterberg H, Blennow K, et al
    Vitamin D supplementation and neurofilament light chain in multiple sclerosis.
    Acta Neurol Scand. 2018 Oct 13. doi: 10.1111/ane.13037.
    PubMed     Text format     Abstract available


  16. BAYART JL, Muls N, van Pesch V
    Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
    Acta Neurol Scand. 2018;138:352-358.
    PubMed     Text format     Abstract available


    August 2018
  17. WESTERBERG E, Landtblom AM, Punga AR
    Life-style factors and disease-specific differences in subgroups of Swedish Myasthenia Gravis.
    Acta Neurol Scand. 2018 Aug 28. doi: 10.1111/ane.13017.
    PubMed     Text format     Abstract available


  18. HAGHIGHI S, Forsmark S, Carlsson A, Nilsson MKL, et al
    Open study with (-)-OSU6162 in multiple sclerosis-related fatigue.
    Acta Neurol Scand. 2018 Aug 22. doi: 10.1111/ane.13007.
    PubMed     Text format     Abstract available


  19. BAUMGARTNER A, Frings L, Schiller F, Stich O, et al
    Regional neuronal activity in patients with relapsing remitting multiple sclerosis.
    Acta Neurol Scand. 2018 Aug 8. doi: 10.1111/ane.13012.
    PubMed     Text format     Abstract available


    July 2018
  20. MURLEY C, Yang F, Gyllensten H, Alexanderson K, et al
    Disposable income trajectories of working-aged individuals with diagnosed multiple sclerosis.
    Acta Neurol Scand. 2018 Jul 24. doi: 10.1111/ane.13001.
    PubMed     Text format     Abstract available


  21. ROMEO MAL, Martinelli V, Dalla Costa G, Colombo B, et al
    Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response.
    Acta Neurol Scand. 2018 Jul 22. doi: 10.1111/ane.12999.
    PubMed     Text format     Abstract available


  22. HAFSTEINSDOTTIR B, Olafsson E, Jakobsson F
    Incidence and outcome of Guillain-Barre syndrome in Iceland: A population-based study.
    Acta Neurol Scand. 2018 Jul 17. doi: 10.1111/ane.13000.
    PubMed     Text format     Abstract available


  23. GAVRILOV YV, Shkilnyuk GG, Valko PO, Stolyarov ID, et al
    Validation of the Russian version of the Fatigue Impact Scale and Fatigue Severity Scale in multiple sclerosis patients.
    Acta Neurol Scand. 2018 Jul 9. doi: 10.1111/ane.12993.
    PubMed     Text format     Abstract available


  24. CANDELIERE MERLICCO A, Gabaldon Torres L, Villaverde Gonzalez R, Fernandez Romero I, et al
    Transorbital ultrasonography for measuring optic nerve atrophy in multiple sclerosis.
    Acta Neurol Scand. 2018 Jul 2. doi: 10.1111/ane.12976.
    PubMed     Text format     Abstract available


  25. JIN S, Long Z, Wang W, Jiang B, et al
    Hyponatremia in neuromyelitis optica spectrum disorders: Literature review.
    Acta Neurol Scand. 2018;138:4-11.
    PubMed     Text format     Abstract available


    June 2018
  26. DALE GH, Svendsen KB, Gjelstrup MC, Christensen T, et al
    Incidence of neuromyelitis optica spectrum disorder in the Central Denmark Region.
    Acta Neurol Scand. 2018;137:582-588.
    PubMed     Text format     Abstract available


    May 2018
  27. CEA G, Martinez D, Salinas R, Vidal C, et al
    Clinical and epidemiological features of myasthenia gravis in Chilean population.
    Acta Neurol Scand. 2018 May 29. doi: 10.1111/ane.12967.
    PubMed     Text format     Abstract available


  28. BERNTSSON SG, Kristoffersson A, Bostrom I, Feresiadou A, et al
    Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor?
    Acta Neurol Scand. 2018 May 24. doi: 10.1111/ane.12963.
    PubMed     Text format     Abstract available


  29. SEBASTIAO E, Motl RW
    Body mass index and cardiorespiratory fitness in persons with multiple sclerosis.
    Acta Neurol Scand. 2018 May 11. doi: 10.1111/ane.12959.
    PubMed     Text format     Abstract available


  30. ABDOLLAHPOUR I, Nedjat S, Mansournia MA, Eckert S, et al
    Infectious exposure, antibiotic use, and multiple sclerosis: A population-based incident case-control study.
    Acta Neurol Scand. 2018 May 9. doi: 10.1111/ane.12958.
    PubMed     Text format     Abstract available


  31. HONG Y, Li HF, Romi F, Skeie GO, et al
    HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis.
    Acta Neurol Scand. 2018 May 7. doi: 10.1111/ane.12951.
    PubMed     Text format     Abstract available


  32. SHU Y, Chang Y, Wu H, Li J, et al
    Serum cystatin C and anti-N-methyl-D-aspartate receptor encephalitis.
    Acta Neurol Scand. 2018;137:515-522.
    PubMed     Text format     Abstract available


    April 2018
  33. AXELSSON M, Sjogren M, Andersen O, Blennow K, et al
    Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barre syndrome: A pilot study.
    Acta Neurol Scand. 2018 Apr 6. doi: 10.1111/ane.12927.
    PubMed     Text format     Abstract available


    March 2018
  34. HEYDARPOUR P, Manouchehrinia A, Beiki O, Mousavi SE, et al
    Smoking and worsening disability in multiple sclerosis: A meta-analysis.
    Acta Neurol Scand. 2018 Mar 15. doi: 10.1111/ane.12916.
    PubMed     Text format     Abstract available


  35. VISTBAKKA J, Sumelahti ML, Lehtimaki T, Elovaara I, et al
    Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patients.
    Acta Neurol Scand. 2018 Mar 12. doi: 10.1111/ane.12921.
    PubMed     Text format     Abstract available


  36. RAHMANZADEH R, Weber MS, Bruck W, Navardi S, et al
    B cells in multiple sclerosis therapy-A comprehensive review.
    Acta Neurol Scand. 2018 Mar 7. doi: 10.1111/ane.12915.
    PubMed     Text format     Abstract available


    February 2018
  37. MANI A, Chohedri E, Ravanfar P, Mowla A, et al
    Efficacy of group cognitive rehabilitation therapy in multiple sclerosis.
    Acta Neurol Scand. 2018 Feb 7. doi: 10.1111/ane.12904.
    PubMed     Text format     Abstract available


  38. GUGER M, Enzinger C, Leutmezer F, Kraus J, et al
    Real-life clinical use of natalizumab and fingolimod in Austria.
    Acta Neurol Scand. 2018;137:181-187.
    PubMed     Text format     Abstract available


  39. AI P, Zhang X, Xie Z, Liu G, et al
    The HMGB1 is increased in CSF of patients with an Anti-NMDAR encephalitis.
    Acta Neurol Scand. 2018;137:277-282.
    PubMed     Text format     Abstract available


  40. NICKEL S, von dem Knesebeck O, Kofahl C
    Self-assessments and determinants of HRQoL in a German MS population.
    Acta Neurol Scand. 2018;137:174-180.
    PubMed     Text format     Abstract available


  41. FALIP M, Rodriguez-Bel L, Castaner S, Miro J, et al
    Musicogenic reflex seizures in epilepsy with glutamic acid decarbocylase antibodies.
    Acta Neurol Scand. 2018;137:272-276.
    PubMed     Text format     Abstract available


    January 2018
  42. CHANDAN S, Shukla G, Gupta A, Srivastava A, et al
    Acute-onset Restless legs syndrome in acute neurological conditions-a prospective study on patients with the Guillain-Barre syndrome and acute stroke.
    Acta Neurol Scand. 2018 Jan 22. doi: 10.1111/ane.12890.
    PubMed     Text format     Abstract available


  43. MESCHERIAKOVA JY, Hintzen RQ
    No excess of autoimmune diseases in multiple sclerosis families from the Netherlands.
    Acta Neurol Scand. 2018 Jan 7. doi: 10.1111/ane.12896.
    PubMed     Text format     Abstract available


  44. RORSMAN I, Petersen C, Nilsson PC
    Cognitive functioning following one-year natalizumab treatment: A non-randomized clinical trial.
    Acta Neurol Scand. 2018;137:117-124.
    PubMed     Text format     Abstract available


    December 2017
  45. OLSSON A, Oturai AB, Sondergaard HB, Sellebjerg F, et al
    Bone microarchitecture and bone mineral density in multiple sclerosis.
    Acta Neurol Scand. 2017 Dec 21. doi: 10.1111/ane.12884.
    PubMed     Text format     Abstract available


  46. ZECCA C, Antozzi CG, Torri Clerici V, Ferrazzini M, et al
    Severe multiple sclerosis reactivation during prolonged lymphopenia after dimethyl fumarate discontinuation.
    Acta Neurol Scand. 2017 Dec 3. doi: 10.1111/ane.12882.
    PubMed     Text format     Abstract available


  47. HEESEN C, Haase R, Melzig S, Poettgen J, et al
    Perceptions on the value of bodily functions in multiple sclerosis.
    Acta Neurol Scand. 2017 Dec 3. doi: 10.1111/ane.12881.
    PubMed     Text format     Abstract available


    November 2017
  48. IBRAHIM J, Grapperon AM, Manfredonia F, van den Bergh PY, et al
    Serial electrophysiology in Guillain-Barre syndrome: A retrospective cohort and case-by-case multicentre analysis.
    Acta Neurol Scand. 2017 Nov 21. doi: 10.1111/ane.12872.
    PubMed     Text format     Abstract available


  49. ZETTERBERG H
    Fluid biomarkers for microglial activation and axonal injury in multiple sclerosis.
    Acta Neurol Scand. 2017;136 Suppl 201:15-17.
    PubMed     Text format     Abstract available


  50. LYCKE J
    Trials of antivirals in the treatment of multiple sclerosis.
    Acta Neurol Scand. 2017;136 Suppl 201:45-48.
    PubMed     Text format     Abstract available


  51. CELIUS EG
    Infections in patients with multiple sclerosis: Implications for disease-modifying therapy.
    Acta Neurol Scand. 2017;136 Suppl 201:34-36.
    PubMed     Text format     Abstract available


  52. WEKERLE H
    Nature, nurture, and microbes: The development of multiple sclerosis.
    Acta Neurol Scand. 2017;136 Suppl 201:22-25.
    PubMed     Text format     Abstract available


  53. FREDERIKSEN JL, Topsoe Mailand M
    Vaccines and multiple sclerosis.
    Acta Neurol Scand. 2017;136 Suppl 201:49-51.
    PubMed     Text format     Abstract available


  54. WENDEL-HAGA M, Celius EG
    Is the hygiene hypothesis relevant for the risk of multiple sclerosis?
    Acta Neurol Scand. 2017;136 Suppl 201:26-30.
    PubMed     Text format     Abstract available


    August 2017
  55. WALLIN MT, Culpepper WJ, Maloni H, Kurtzke JF, et al
    The Gulf War era multiple sclerosis cohort: 3. Early clinical features.
    Acta Neurol Scand. 2017 Aug 22. doi: 10.1111/ane.12810.
    PubMed     Text format     Abstract available


    July 2017
  56. ANDERSEN O, Hildeman A, Longfils M, Tedeholm H, et al
    Diffusion tensor imaging in multiple sclerosis at different final outcomes.
    Acta Neurol Scand. 2017 Jul 25. doi: 10.1111/ane.12797.
    PubMed     Text format     Abstract available


  57. CAMBRON M, Hadhoum N, Duhin E, Lacour A, et al
    JCV serology in time: 3 years of follow-up.
    Acta Neurol Scand. 2017;136:54-58.
    PubMed     Text format     Abstract available


    June 2017
  58. GUAN Z, Shang L, Zhang W, Guo Y, et al
    A rating scale for the severity of Guillain-Barre syndrome.
    Acta Neurol Scand. 2017 Jun 14. doi: 10.1111/ane.12786.
    PubMed     Text format     Abstract available


  59. OTTO M, Markvardsen L, Tankisi H, Jakobsen J, et al
    The electrophysiological response to immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
    Acta Neurol Scand. 2017;135:656-662.
    PubMed     Text format     Abstract available


    May 2017
  60. MENTIS AA, Dardiotis E, Grigoriadis N, Petinaki E, et al
    Viruses and endogenous retroviruses in multiple sclerosis: From correlation to causation.
    Acta Neurol Scand. 2017 May 23. doi: 10.1111/ane.12775.
    PubMed     Text format     Abstract available


    April 2017
  61. MARTINELLI V, Dalla Costa G, Messina MJ, Di Maggio G, et al
    Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromes.
    Acta Neurol Scand. 2017 Apr 9. doi: 10.1111/ane.12761.
    PubMed     Text format     Abstract available


    March 2017
  62. ELKJAER ML, Molnar T, Illes Z
    Teriflunomide for multiple sclerosis in real-world setting.
    Acta Neurol Scand. 2017 Mar 20. doi: 10.1111/ane.12755.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: